Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 5/20 | 0.54 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.54 |
| ▸ | MAOB | P27338 | 2/20 | 0.44 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.43 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | CHAT | P28329 | 2/20 | 0.40 |
| ▸ | FGF23 | Q9GZV9 | 1/20 | 0.39 |
| ▸ | DPYD | Q12882 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14690157 | 1.00 | NFE2L2 (0.54) | NFE2L2TRPA1MAOBSIGMAR1CYP19A1 | |
| SCHEMBL14690153 | 1.00 | NFE2L2 (0.54) | NFE2L2TRPA1MAOBSIGMAR1CYP19A1 | |
| SCHEMBL27805506 | 0.92 | NFE2L2 (0.47) | NFE2L2TRPA1MAOBSIGMAR1CYP19A1 | |
| Methane SCHEMBL27583285 | 0.90 | NFE2L2 (0.46) | NFE2L2TRPA1MAOBSIGMAR1CYP19A1 | |
| SCHEMBL14690304 | 0.90 | NQO2 (0.47) | NFE2L2TRPA1MAOBSIGMAR1CYP19A1 | |
| SCHEMBL14690301 | 0.90 | NQO2 (0.47) | NFE2L2TRPA1MAOBSIGMAR1CYP19A1 | |
| SCHEMBL14690303 | 0.90 | NQO2 (0.47) | NFE2L2TRPA1MAOBSIGMAR1CYP19A1 | |
| SCHEMBL10622271 | 0.86 | CHAT (0.47) | NFE2L2TRPA1CHAT | |
| SCHEMBL13932212 | 0.83 | NFE2L2 (0.50) | NFE2L2TRPA1MAOBSIGMAR1CYP19A1 | |
| SCHEMBL27830937 | 0.81 | NFE2L2 (0.48) | NFE2L2TRPA1MAOBSIGMAR1CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118638434-A | Preparation method of yellow azo oxide and azo stilbene dye | 洛阳美伦色彩科技有限公司 | 2024-09-13 | — | — | CN | claimed |
| EP-4707341-A1 | METHOD FOR PREPARING YELLOW AZO OXIDE AND AZO DISTYRYLBENZENE DYES | Luoyang Meilun Color Technology Co., Ltd. (CN) | 2026-03-11 | — | — | EP | disclosed |
| CN-118638434-B | Preparation method of yellow azo oxide and azo stilbene dye | 洛阳美伦色彩科技有限公司 | 2025-07-25 | — | — | CN | disclosed |
| CN-118638434-B | Preparation method of yellow azo oxide and azo stilbene dye | 洛阳美伦色彩科技有限公司 | 2025-07-25 | — | — | CN | disclosed |
| CN-112105912-B | Method and apparatus for single biological nanoparticle analysis | 华盛顿大学 | 2025-05-23 | — | — | CN | disclosed |
| US-20240409525-A1 | NATURALLY AVAILABLE FRUIT-DERIVED COMPOUNDS TESTED TO DOCK WITH PRESENILIN-1 AND AMYLOID PRECURSOR PROTEIN | DASGUPTA SUBHAJIT (US) | 2024-12-12 | — | — | US | disclosed |
| CN-113874766-B | Polarizing plate for folding display | 东洋纺株式会社 | 2024-11-12 | — | — | CN | disclosed |
| CN-118638434-A | Preparation method of yellow azo oxide and azo stilbene dye | 洛阳美伦色彩科技有限公司 | 2024-09-13 | — | — | CN | disclosed |
| CN-118638434-A | Preparation method of yellow azo oxide and azo stilbene dye | 洛阳美伦色彩科技有限公司 | 2024-09-13 | — | — | CN | disclosed |
| CN-118638434-A | Preparation method of yellow azo oxide and azo stilbene dye | 洛阳美伦色彩科技有限公司 | 2024-09-13 | — | — | CN | disclosed |
| CN-112771422-B | Film for transferring alignment layer of liquid crystal compound | 东洋纺株式会社 | 2023-10-24 | — | — | CN | disclosed |
| CN-116804778-A | Alignment film for transfer of alignment layer of liquid crystal compound | 东洋纺株式会社 | 2023-09-26 | — | — | CN | disclosed |
| CN-116606557-A | Method for preparing azo dye | 昂高知识产权有限公司 | 2023-08-18 | — | — | CN | disclosed |
| CN-112805136-B | Alignment film for transfer of alignment layer of liquid crystal compound | 东洋纺株式会社 | 2023-06-20 | — | — | CN | disclosed |
| CN-115335222-A | Laminate for thin film layer transfer | 东洋纺株式会社 | 2022-11-11 | — | — | CN | disclosed |
| US-9890351-B2 | Encapsulates | THE PROCTER & GAMBLE COMPANY (US) | 2018-02-13 | — | — | US | disclosed |
| EP-2741731-B1 | ENCAPSULATES | PROCTER & GAMBLE (US) | 2017-05-17 | — | — | EP | disclosed |
| EP-2741731-A1 | ENCAPSULATES | The Procter and Gamble Company (US) | 2014-06-18 | — | — | EP | disclosed |
| US-20130039962-A1 | ENCAPSULATES | ENCAPSYS, LLC | 2013-02-14 | — | — | US | disclosed |
| WO-2013022949-A1 | ENCAPSULATES | THE PROCTER & GAMBLE COMPANY (US) | 2013-02-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130039962-A1 | ENCAPSULATES | ABCB4, PPIB, FLNB | NFE2L2 3370/4885TRPA1 942/4885MAOB 266/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.